Koshinski Asset Management Inc. raised its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,292 shares of the company’s stock after purchasing an additional 558 shares during the period. Koshinski Asset Management Inc.’s holdings in Colgate-Palmolive were worth $754,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive during the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the 3rd quarter valued at about $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive during the 3rd quarter valued at about $64,000. True Wealth Design LLC boosted its stake in Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after purchasing an additional 672 shares during the period. Finally, Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after acquiring an additional 368 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Stock Down 0.8 %
CL stock opened at $87.53 on Thursday. The firm has a market capitalization of $71.51 billion, a P/E ratio of 25.08, a P/E/G ratio of 3.64 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The company’s 50 day simple moving average is $92.07 and its 200-day simple moving average is $97.65. Colgate-Palmolive has a 52-week low of $80.03 and a 52-week high of $109.30.
Colgate-Palmolive Announces Dividend
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on CL. UBS Group reduced their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Piper Sandler reduced their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Stifel Nicolaus reduced their price target on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a research note on Friday, January 17th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $101.11.
View Our Latest Analysis on CL
Insider Buying and Selling at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.37% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- About the Markup Calculator
- Oracle Announces Game-Changing News for the AI Industry
- When to Sell a Stock for Profit or Loss
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- The Risks of Owning Bonds
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.